Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Studies of prognosis for surgery and corticosteroid injection for carpal tunnel syndrome (CTS) have considered only a limited range of explanatory variables for outcome.
Methods: Data were prospectively collected on patient-reported symptoms, physical and psychological functioning, comorbidity, and quality of life at baseline and every 6 months for up to 2 years. Outcomes were patient-rated change over a 6-month period and symptom-severity score at 18 months.
Results: In total, 754 patients with CTS completed baseline questionnaires, and 626 (83%) completed follow-up to 18 months. Multivariable modeling identified, independent of symptom severity at outset, higher health utility, fewer comorbidities, and lower anxiety as significant predictors of better outcome from surgery. In patients treated by steroid injection, independent of symptom severity at outset, shorter duration of symptoms and having no prior injection were significant predictors of better outcome.
Discussion: These multivariable models of outcome may inform shared decision making about treatment for CTS. Muscle Nerve, 2019.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mus.26459 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Acute graft-versus-host disease therapy: Which third line treatment after steroids and ruxolitinib? (SFGM-TC)].
Bull Cancer
September 2025
Service d'hématologie, département d'oncologie, hôpitaux universitaire de Genève (HUG), faculté de médecine, université de Genève, Genève, Suisse. Electronic address:
Acute graft-versus-host disease (GVHDa) is one of the leading causes of morbidity and mortality after allogeneic hematopoietic stem cell transplant (HSCT) patients. While the first-line consensus treatment has been based on systemic corticosteroid therapy for many years, ruxolitinib has recently been approved and has become the standard second-line treatment. Nevertheless, the effectiveness of ruxolitinib remains limited to 40 % of cortico-resistant patients, raising the crucial question of selecting a third-line treatment.
View Article and Find Full Text PDFOsteoarthritis year in review 2025: Epidemiology and Therapy.
Osteoarthritis Cartilage
September 2025
Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address:
Aim: To summarise key epidemiological and therapeutic research on osteoarthritis (OA) published between April 2024 and March 2025.
Methods: A narrative review was conducted using the MEDLINE database, focusing on English-language studies involving human participants published between April 1, 2024 and March 31, 2025. Eligible studies included observational longitudinal studies, systematic reviews, meta-analyses, and phase II-IV randomised controlled trials (RCTs) examining OA treatment and epidemiology.
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial.
Lancet Rheumatol
September 2025
National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. Electronic address:
Background: The optimal treatment strategy in early psoriatic arthritis remains unknown. We aimed to assess whether the combination of methotrexate and golimumab plus corticosteroids is superior to methotrexate plus corticosteroids in reducing disease activity in early, untreated psoriatic arthritis.
Methods: We did a double-blind, randomised, placebo-controlled, parallel-group, single-centre study in adults with treatment-naïve active psoriatic arthritis.
Comparison of PRP Injections Versus Corticosteroid Injections in Plantar Fasciitis: Systematic Review and Meta-analysis.
Foot Ankle Spec
September 2025
University of Seville, Sevilla, Spain.
Background: Plantar fasciitis (PF) is a common condition, affecting 10% of adults and accounting for 15% of foot pain consultations. Although 90% of cases resolve within 12 months with conservative treatments, chronic cases require more invasive treatments. Risk factors include a high body mass index and anatomical foot disorders.
View Article and Find Full Text PDFCompressive Neuropathy in the Upper Extremity: Pathophysiology, Diagnosis, and Treatment.
Ann Plast Surg
September 2025
From the Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN.
Background: Compressive neuropathy in the upper extremity is a common and often debilitating condition that significantly impacts function and quality of life. Despite its prevalence, the diagnosis, and management of compressive neuropathies remain complex with promising innovations. Plastic surgeons play a critical role in both surgical and nonsurgical interventions for these conditions.
View Article and Find Full Text PDF